Stereotactic body radiotherapy for hepatocellular carcinoma: Five-year prospective registry outcomes from an Australian tertiary transplant centre

Figure 1 Treatment outcomes. A: Local control rates, with death and distant progression as competing events; B: Progression-free survival, with failure defined as death, distant relapse, extrahepatic failure, or local failure; C: Cumulative incidence of local failure, with death, distant intrahepatic relapse, and extrahepatic failure as competing events.